Keyphrases
Allergic Asthma
100%
Sublingual Immunotherapy
72%
Antibiotics
40%
Asthma Exacerbation
38%
Infection Risk
33%
Epidemiological Study
33%
Lower Respiratory Tract Infection
33%
House Dust Mite
33%
Double-blind Randomized Controlled Trial
33%
Antiviral Immunity
33%
Airway Epithelial
33%
Impact Stability
33%
Clinical Impact
33%
Acute Exacerbation
33%
Recurrent Exacerbations
33%
Genome Stability
33%
Clinical Phenotype
33%
Hospitalized Adults
33%
Sublingual
28%
Respiratory Infection
26%
Asthma
23%
Odds Ratio
16%
Atopic Asthma
16%
Bronchial Epithelial Cells
14%
Risk Factors
11%
Confidence Interval
11%
Protective Effect
11%
Allergy
11%
Nationwide Population
11%
Anti-allergic
11%
Placebo
9%
Polyinosinic-polycytidylic Acid
9%
Human Bronchial Epithelial Cells
9%
Viral
9%
Perennial Allergy
8%
Respiratory Exacerbation
8%
Register-based
8%
Rural Residence
5%
Subgroup Analysis
5%
Prospective Follow-up
5%
Major Risk Factors
5%
Prescription Drug Misuse
5%
Seasonal Allergies
5%
Rural-urban
5%
Viral Infection
5%
Asthma Severity
5%
Register Data
5%
Prescription Refill
5%
Prescription Database
5%
Antibiotic Prescription
5%
Immunology and Microbiology
Allergic Asthma
100%
Asthma
72%
Allergen Immunotherapy
71%
Asthma Exacerbation
38%
Lower Respiratory Tract
33%
Dermatophagoides
33%
Antiviral Immunity
33%
Eosinophil
11%
Polyinosinic:polycytidylic Acid
9%
Viral Disease
9%
